Showing 20 of 33 recruiting trials for “catastrophic-antiphospholipid-syndrome”
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
🏥 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.📍 70 sites📅 Started Dec 2025View details ↗
RecruitingNCT07372170 ↗
Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients
👨⚕️ Anabel Franco-Moreno, MD, PhD, Sociedad Española De Medicina Interna📍 2 sites📅 Started Dec 2025View details ↗
Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS)
A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 2 sites📅 Started Jul 2025View details ↗
Zhibitai Capsules for the Treatment of Primary Hyperlipidemia
A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors
Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
👨⚕️ Sponsor Chugai Pharmaceutical Co.Ltd, clinical-trials@chugai-pharm.co.jp📍 54 sites📅 Started Dec 2024View details ↗
Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets
RecruitingNCT06373003 ↗
Negative Antiphospholipid Syndrome: a Multicentric Study
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
👨⚕️ Sponsor Chugai Pharmaceutical Co.Ltd, clinical-trials@chugai-pharm.co.jp📍 67 sites📅 Started Aug 2024View details ↗
Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands
Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin
Effect of Belimumab on Antibody Titers in Primary APS Patients
A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
👨⚕️ Seung-Hoon Lee, MD, PhD, Seoul National University Hospital📍 32 sites📅 Started Feb 2024View details ↗
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
👨⚕️ George Triadafilopoulos, Silicon Valley Gastroenterology📍 1 site📅 Started Feb 2024View details ↗
Anti-CD38 Antibody Treating APS With Thrombocytopenia
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Aug 2023View details ↗
Daratumumab in Primary Antiphospholipid Syndrome
👨⚕️ Doruk Erkan, M.D., M.P.H., Hospital for Special Surgery, New York: Division of Rheumatology📍 8 sites📅 Started May 2023View details ↗
RecruitingNCT05679206 ↗
Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →